This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1 A Ascherio , EB Rimm , EL Giovannucci , (1996) Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States. BMJ 313, 84–90.
2 P Pietinen , A Ascherio , P Korhonen , (1997) Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Epidemiol 145, 876–887.
3 K Oh , FB Hu , JE Manson , (2005) Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the Nurses' Health Study. Am J Epidemiol 161, 672–679.
4 CM Oomen , MC Ocke , EJ Feskens , (2001) Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet 357, 746–751.
6 T Pars , M Osler & P Bjerregaard (2001) Contemporary use of traditional food among Greenlandic Inuit. Arctic 54, 22–31.
9 E Searles (2002) Food and the making of Inuit identity. Food Foodways 10, 55–78.
12 Q Sun , J Ma , H Campos , (2007) A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease. Circulation 115, 1858–1865.
13 EK Kabagambe , MY Tsai , PN Hopkins , (2008) Erythrocyte fatty acid composition and the metabolic syndrome: a National Heart, Lung, and Blood Institute GOLDN study. Clin Chem 54, 154–162.
17 D Mozaffarian , MB Katan , A Ascherio , (2006) Medical progress – trans fatty acids and cardiovascular disease. N Engl J Med 354, 1601–1613.
19 NA Shaikh & E Downar (1981) Time course of changes in porcine myocardial phospholipid levels during ischemia. A reassessment of the lysolipid hypothesis. Circ Res 49, 316–325.
22 AJ Tremblay , H Morrissette , JM Gagne , (2004) Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with β-quantification in a large population. Clin Biochem 37, 785–790.
23 B Lamarche , A Tchernof , P Mauriege , (1998) Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA 279, 1955–1961.
24 AC St-Pierre , IL Ruel , B Cantin , (2001) Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease. Circulation 104, 2295–2299.
25 DR Matthews , JP Hosker , AS Rudenski , (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419.
26 TG Pickering , JE Hall , LJ Appel , (2005) Recommendations for blood pressure measurement in humans: an AHA scientific statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee. J Clin Hypertens (Greenwich) 7, 102–109.
29 J Genest (2008) The Yin and Yang of high-density lipoprotein cholesterol. J Am Coll Cardiol 51, 643–644.
30 MJ Stampfer , FM Sacks , S Salvini , (1991) A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med 325, 373–381.
31 RP Mensink & MB Katan (1990) Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. N Engl J Med 323, 439–445.
33 AH Lichtenstein , LM Ausman , SM Jalbert , (1999) Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels. N Engl J Med 340, 1933–1940.
34 NR Matthan , FK Welty , PH Barrett , (2004) Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women. Arterioscler Thromb Vasc Biol 24, 1092–1097.
36 SH Mitmesser & TP Carr (2005) Trans fatty acids alter the lipid composition and size of apoB-100-containing lipoproteins secreted by HepG2 cells. J Nutr Biochem 16, 178–183.
37 KK Berneis & RM Krauss (2002) Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res 43, 1363–1379.
38 FM Sacks & H Campos (2003) Clinical review 163. Cardiovascular endocrinology: low-density lipoprotein size and cardiovascular disease: a reappraisal. J Clin Endocrinol Metab 88, 4525–4532.
41 J Dyerberg , DC Eskesen , PW Andersen , (2004) Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8 weeks dietary intervention study. Eur J Clin Nutr 58, 1062–1070.
42 JE Roeters van Lennep , HT Westerveld , DW Erkelens , (2002) Risk factors for coronary heart disease: implications of gender. Cardiovasc Res 53, 538–549.
45 RH Knopp , P Paramsothy , BM Retzlaff , (2006) Sex differences in lipoprotein metabolism and dietary response: basis in hormonal differences and implications for cardiovascular disease. Curr Cardiol Rep 8, 452–459.
47 A Lapointe , EM Balk & AH Lichtenstein (2006) Gender differences in plasma lipid response to dietary fat. Nutr Rev 64, 234–249.
48 GR Cooper , GL Myers , SJ Smith , (1992) Blood lipid measurements. Variations and practical utility. JAMA 267, 1652–1660.
49 MA Pereira , AI Kartashov , CB Ebbeling , (2005) Fast-food habits, weight gain, and insulin resistance (the CARDIA study): 15-year prospective analysis. Lancet 365, 36–42.
50 FB Hu , TY Li , GA Colditz , (2003) Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA 289, 1785–1791.
51American Diabetes Association (2008) Standards of medical care in diabetes – 2008. Diabetes Care 31, Suppl. 1, S12–S54.
52 AV Chobanian , GL Bakris , HR Black , (2003) Seventh report of the Joint National Committee on Prevention. Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42, 1206–1252.